![Glenn Noronha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenn Noronha
Corporate Officer/Principal presso
The Association for Research in Vision & Ophthalmology
Profilo
Glenn Noronha is a professional with a doctorate degree from Loyola University of Chicago.
He is currently a member of The Association for Research in Vision & Ophthalmology.
In the past, he held positions such as Associate Director-Medicinal Chemistry at TargeGen, Project Head-Global Retinal Development at Alcon Laboratories, Vice President-Research & Development at Sucampo Pharma Americas, and Chief Scientific Officer at Clearside Biomedical, Theriac Pharma Corp., JW Therapeutics (Shanghai) Co., Ltd., Navire Pharma, Inc., and BridgeBio Pharma, Inc. He was also a Research Scientist & Project Leader at Medtronic MiniMed, Inc. from 2000 to 2002.
He will be the Chief Development Officer at PYC Therapeutics Ltd. from 2021 to 2023.
Posizioni attive di Glenn Noronha
| Società | Posizione | Inizio |
|---|---|---|
The Association for Research in Vision & Ophthalmology
 The Association for Research in Vision & Ophthalmology Miscellaneous Commercial ServicesCommercial Services Operates association for research in vision and ophthalmology | Corporate Officer/Principal | - |
Precedenti posizioni note di Glenn Noronha
| Società | Posizione | Fine |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Corporate Officer/Principal | 01/01/2023 |
| CLEARSIDE BIOMEDICAL | Direttore Tecnico/Scientifico/R&S | 01/12/2018 |
Sucampo Pharma Americas, Inc. | Direttore Tecnico/Scientifico/R&S | 01/05/2013 |
Theriac Pharma Corp. | Direttore Tecnico/Scientifico/R&S | 01/07/2012 |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Corporate Officer/Principal | 01/01/2011 |
Formazione di Glenn Noronha
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
70
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Health Technology |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Health Technology |
Loyola University of Chicago
 Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
Medtronic MiniMed, Inc.
 Medtronic MiniMed, Inc. Medical SpecialtiesHealth Technology Manufactures insulin pumps and glucose monitoring systems | Health Technology |
The Association for Research in Vision & Ophthalmology
The Association for Research in Vision & Ophthalmology Miscellaneous Commercial ServicesCommercial Services Operates association for research in vision and ophthalmology | Commercial Services |
Sucampo Pharma Americas, Inc. | |
Clearside Biomedical, Inc.
 Clearside Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures suprachoroidal space injections for eye diseases | Health Technology |
Theriac Pharma Corp. | |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Health Technology |
Navire Pharma, Inc.
 Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
